Women's Health Medicine
Volume 3, Issue 3 , Pages 106-107, 1 May 2006

Management of polycystic ovary syndrome

Stephen Franks FMedSci is Professor of Reproductive Endocrinology at Imperial College Faculty of Medicine, St Mary's and the Hammersmith Hospitals, London, UK. Conflicts of interest: none declared.

Abstract 

Polycystic ovary syndrome can cause distressing symptoms of hyperandrogenism (such as hirsutism), may impair fertility and is associated with the metabolic syndrome. Management has traditionally been guided by symptoms or by the wish to conceive, but prevention of the possible long-term consequences of the metabolic disturbance characteristic of anovulatory women with PCOS is now an important element of management. By focusing on the treatment of infertility, menstrual regulation, the treatment of symptoms of hyperandrogenism and the prevention of possible consequences of the metabolic disturbance, this article reviews the important elements in the management of PCOS

Keywords:  polycystic ovary syndrome , hirsutism , clomiphene , follicle-stimulating hormone (FSH) , metformin , acne

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 9.95 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1744-1870(06)70175-5

doi:10.1383/wohm.2006.3.3.106

Women's Health Medicine
Volume 3, Issue 3 , Pages 106-107, 1 May 2006